OPEN CALL FOR GROUP LEADERS at CMR[B]
The Centre of Regenerative Medicine of Barcelona CMR[B] is looking for ambitious and highly motivated scientists with an outstanding track record to apply for independent tenure-track Group Leader research positions.
The deadline for the applications is September 30th 2019
At CMR[B], Group leaders benefit from:
• An advancing, international and collaborative environment
• A flexible start up package to set-up the lab, the initial team and to cover lab expenses
• Access to cutting edge core facilities
• Training in collaboration with other institutions
• Tailored support in raising competitive funds
A creative and collaborative environment to nurture excellence
CMR[B] is a non-profit foundation established in July 2004 by the Catalan Government, represented by the Catalan Ministry of Health, and Spanish Ministry of Health, represented by the Carlos III Healthcare Institute. Originally located at the PRBB, the CMR[B] has recently moved to the Bellvitge Campus area, a biomedical and biotechnology cluster of health care facilities, knowledge-generating institutions, research centres and companies of the sector of life sciences and health. In constant growth, the area is becoming one of the most dynamic and innovative places in the country in terms of health and biomedical research.
The overall mission of CMR[B] is to conduct fundamental research of excellence for advancing the clinical translation of regenerative medicine strategies. Therefore, the focus of CMR[B] research activities is addressed at enabling cell- and tissue-based regenerative therapies to become a clinical reality, using a goal-oriented approach, with specific disease/organ targets as focus. CMR[B], as a research centre, is not a monographic centre devoted to a specific disease, but generates knowledge at various steps of the bench-to-bed translation path, possibly directed to be applied to a variety of disease conditions. The successful implementation of regenerative medicine strategies is expected to transform the way chronic degenerative diseases are currently treated, thus having a huge impact on the span and quality of life of patients, and on the overall toll these diseases take on the healthcare system.
The activities of the Research Centre focus mainly on developing and implementing regenerative medicine approaches, which make use of cell and tissue therapy to replace cells and tissues damaged or lost as a result of degenerative diseases.
Interested candidates must send an updated resume, a motivation letter, a brief outline of future research plans (2-3 pages max) and contact details of three referees to firstname.lastname@example.org by September 30th, 2019 citing the reference GL_2019 as the subject line. Informal inquiries are welcome and must be addressed to the Director of the centre, Prof. Angel Raya at email@example.com
Candidates pre-selected by an international scientific committee will be invited for an on-site interview by mid November 2019 at the CMR[B]. The panel will consist of the internal selection committee and members of the international scientific advisory board.
An official offer letter will be issued in writing to the selected candidates.
Successful candidates of the Group Leader position will lead an independent research group with no teaching obligations and will be appointed for an initial 4-year tenure-track period, starting during 2020.
We offer a flexible start-up package that covers salaries and consumables for up to three positions.
CMR[B] group leaders benefit from a highly collaborative, approachable and international English-speaking environment.
We provide fully equipped laboratory space for up to 6-8 people, priority access to on-site facilities and access to additional special equipment if required.
Besides the laboratories and stem cell culture facilities, CMR[B] includes a complete Core Facility Unit, offering support in Aquatic Animals, Bioimaging and Histology, Flow Cytometry, Advanced Cell Culture, and Embryo Micromanipulation Platforms.
The CMR[B] also houses the Stem Cell Bank of Barcelona (BLCB), a node of the Carlos III Healthcare Institute’s National Stem Cell Bank, dedicated to the derivation, maintenance, characterization and preservation of pluripotent stem cells, with the aim of developing research activities in the area of regenerative medicine.
CMRB policy of equal opportunities
The CMR[B] is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission. Thus, there are no restrictions of citizenship or gender and candidates with disabilities are strongly encouraged to apply.
Please note: In accordance with the LOPD 3/2018, we inform you that your data will be stored in an internal database of the centre in order to carry out the usual processes of human resource management. In accordance with the Act you have the right to access, modify, cancel or oppose to the use we give to them. In this case you have to contact the Administration/HHRR of the CMRB or email firstname.lastname@example.org